content

Researchers from Uppsala University in Sweden have released a study on how various antibiotic treatments affect different types of bacteria and how they respond...

CardieX Limited, a global health technology company focused on patient-centric healthcare research and improving clinical trial patient outcomes announced a partnership between its ATCOR...

Hetero, India’s leading pharmaceutical company with the widest global reach, announced the receipt of World Health Organization Prequalification of Medicines Program (WHO PQ) approval...

WuXi STA, a subsidiary of WuXi AppTec, announced that its first drug product Continuous Manufacturing (CM) line for oral solids is in operation at...

The Japanese Ministry of Health, Labor, and Welfare (MHLW) has approved AstraZeneca’s immunotherapies Imfinzi (durvalumab) and Imjudo (tremelimumab) to treat advanced liver, biliary tract,...

Cellectis has entered into a strategic collaboration agreement with Primera Therapeutics to develop a gene editing platform to treat mitochondrial diseases. Primera Therapeutics is launched...

BDR Pharmaceutical has launched the first generic apalutamide in India to treat both metastatic castration sensitive prostate cancer as well as non-metastatic castration resistant...